Welcome to the new TheAnswerPage!
TheAnswerPage is a medical education resource that has been providing the highest quality accredited education to the healthcare community for over 25 years. Awarded in the US and internationally, TheAnswerPage is now a recognized leader for providing comprehensive education on the endocannabinoid system and medical cannabis, pain medicine and opioid prescribing practices. Accredited content provides Accreditation Council for Continuing Medical Education (ACCME – AMA PRA Category 1 Credits™), Accreditation Council for Pharmacy Education (ACPE), American Academy of Nurse Practitioners (AANP), American Nurses Credentialing Center (ANCC), and American General Dentistry (AGD) credits.
TheAnswerPage creates tailored medical cannabis educational programs for Departments of Public Health, state medical societies, hospitals and medical schools. TheAnswerPage is the only education company where the Founding Editor-in-Chief and Editor-in-Chief trained and served together with distinction at Harvard Medical School and their affiliated teaching hospitals, and have both been the recipients of numerous awards, including the “Medical Professional of the Year Award” presented by the Americans for Safe Access (ASA) and the “Special Award for Medical Cannabis Education” bestowed by the International Association of Cannabinoid Medicine (IACM).
“TheAnswerPage is the resource that I recommend for accredited education on the endocannabinoid system, medical cannabis, opioid prescribing, and pain medicine.”
Professor Raphael Mechoulam
Faculty of Medicine, The Hebrew University of Jerusalem, Member, Israel Academy of Science
Top Learning Content Categories
Your Dose of Cannabis Education
Only have a minute but want to Learn something every day™? Sign up to receive Your Dose of Cannabis Education, bringing featured content from our course library right to your inbox each day.
What cautionary measures should be taken when prescribing fentanyl for breakthrough pain?
Patients who are not opioid tolerant are at risk for developing sever hypoventilation, when given fentanyl for breakthrough pain.